Established in January 2017, Jiangsu Rongtai Bio-Technology Co., Ltd. is a R&D company specialized in the researches on biomacromolecules and related drugs. Focusing on the development of fusion protein drugs in various diseases, including inflammation, pain and tumor, this company have mature technology platform for fusion protein expression